Russian lawmaker calls German election outcome ‘predictable’Russian Politics & Diplomacy September 25, 10:46
Russian-Chinese naval drills ‘Joint Sea 2017’ completed in VladivostokMilitary & Defense September 25, 10:29
Independence referendum underway in Iraqi KurdistanWorld September 25, 9:47
Russia and US have no plans to curtail space cooperationScience & Space September 25, 9:30
Denis Matsuev: That extraordinary idea workedSociety & Culture September 25, 8:00
Tehran's top diplomat slams 'fake' empathy from Trump for IraniansWorld September 25, 6:06
Merkel wins Bundestag electionsWorld September 25, 5:37
Expert says North Korea won’t test thermonuclear warhead in Pacific OceanWorld September 25, 4:26
Russian senator believes German Social Democrats seek to improve ties with MoscowRussian Politics & Diplomacy September 25, 2:42
BASEL, January 29. /ITAR-TASS/. Russia ranks second by the pharmaceutical market of over-the-counter medications, goes a report of the multinational pharmaceutical corporation Novartis.
According to the statements, the country became the world's second largest market and the strongest driver in this segment with its “double-digit growth” of over-the-counter drug sales.
As for the brands popular in Russia, Novartis cites anti-inflammatory drug Voltaren, nasal spray Otrivin and cold symptom-fighting powder Theraflu. Growth in sales of the two latter drugs increased due to cold winter, Novartis explains.
2013 financial statements came out on Wednesday showing Novartis’ revenue 2.2% up to 57.92 billion. Net profit declined 1% to 9.3 billion.
The company does not disclose over-the-counter sales summing the figure up with revenue from veterinary drugs. Sales in the segment grew 8.8% to 4.06 billion in 2013.
Novartis International AG set up in 1996 is Europe’s second pharmaceutical producer by market share with 120,000 employees operating in 140 countries. In Russia, Novartis has three kinds of businesses: over-the-counter medications, contact lenses and veterinary drugs.